Widening the Therapeutic Perspectives of Clofazimine by Its Loading in Sulfobutylether β-Cyclodextrin Nanocarriers: Nanomolar IC50 Values against MDR S. epidermidis
- 19 July 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 15 (9) , 3823-3836
Abstract
Clofazimine (CLZ) is an antibiotic with promising behavior against gram positive bacteria however the drug is completely insoluble in water and accumulates in fat tissues. We explored nanocarriers, labeled and not with rhodamine, consisting of negatively charged sulfobutylether-β-cyclodextrins for CLZ loading. A new oligomeric carrier was obtained crosslinking βCyD with epichlorohydrin followed by sulfonation in strongly alkaline aqueous medium. The oligomeric carrier has MW of 53 kDa, and forms small nanoparticles of few tens of nm. With aqueous solutions containing 25 mg/ml oligomeric carrier we loaded up to 0.5 mg/ml drug. The oligomeres exhibit a tenfold better loading capacity compared to monomers and nanoparticles with size in the 20-60 nm range after drug loading. Circular dichroism confirmed encapsulation of the CLZ in the nanocarriers. All carriers with or without CLZ are not cytotoxic up to 1 M, while CLZ alone is highly cytotoxic at the same concentration. The drug has IC50 values below 100 nM against S. epidermidis. The same holds also for clinical isolates of S epidermidis, some displaying MDR. So, the selectivity index significantly increased for CLZ/carrier systems compared to the drug alone. Taken all together our results open new avenues for the clinical application of this antibiotic.Keywords
Funding Information
- FP7 People: Marie-Curie Actions (608407)
This publication has 41 references indexed in Scilit:
- Current applications of nanoparticles in infectious diseasesJournal of Controlled Release, 2016
- An efficient system for intracellular delivery of beta-lactam antibiotics to overcome bacterial resistanceScientific Reports, 2015
- Nanotechnology as a therapeutic tool to combat microbial resistanceAdvanced Drug Delivery Reviews, 2013
- Nanoparticles Functionalized with Ampicillin Destroy Multiple-Antibiotic-Resistant Isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and Methicillin-Resistant Staphylococcus aureusApplied and Environmental Microbiology, 2012
- Host–guest interactions mediated nano-assemblies using cyclodextrin-containing hydrophilic polymers and their biomedical applicationsNano Today, 2010
- Cyclodextrin-Based Polymeric Materials: Synthesis, Properties, and Pharmaceutical/Biomedical ApplicationsBiomacromolecules, 2009
- Design and development of IT-101, a cyclodextrin-containing polymer conjugate of camptothecinAdvanced Drug Delivery Reviews, 2009
- Recent advances and future directions in amphiphilic cyclodextrin nanoparticlesExpert Opinion on Drug Delivery, 2009
- Cyclodextrin-based pharmaceutics: past, present and futureNature Reviews Drug Discovery, 2004
- Preparation and characterization of water soluble high molecular weight β-cyclodextrin-epichlorohydrin polymersEuropean Polymer Journal, 1997